We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
What research and consultancy services Cefas provides, what legislation you need to comply with, and how to meet those requirements.
How to assess a planning application when there are protected species on or near a proposed development site.
Why it's important to evaluate digital health products that have been developed rapidly and how to choose evaluation methods in these circumstances.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Information on methyl ethyl ketone (MEK) (also known as 2-butanone) for use in responding to chemical incidents.
Photosensitivity reactions are known side effects of methotrexate treatment and can be severe. Patients should be advised to take precautions to protect their skin in the sun.
Information about suspected side effects of e-cigarettes and how to report side effects.
Organisational definitions of terms concerned with risk and risk-related matters.
How a competent authority must decide if a plan or project proposal that affects a European site can go ahead.
Information on depleted uranium (DU) including what it is, its uses, health effects and protection from exposure.
This guide explains how impacts on noise should be incorporated into a cost benefit analysis.
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Guidance on acetic acid (also known as ethanoic acid) for use in responding to chemical incidents.
Explains requirements of the Town and Country Planning (Environmental Impact Assessment) Regulations 2017.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).